High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer

被引:38
作者
Kristiansen, M
Knudsen, GPS
Maguire, P
Margolin, S
Pedersen, J
Lindblom, A
Orstavik, KH [1 ]
机构
[1] Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway
[2] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
[3] Karolinska Univ Hosp Sodersjukhuset, Dept Oncol, Stockholm, Sweden
[4] Univ Oslo, Rikshosp, Fac Div, N-0027 Oslo, Norway
关键词
D O I
10.1136/jmg.2005.032433
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: A higher frequency of skewed X chromosome inactivation has been reported in a consecutive series of young patients with breast cancer compared with controls of a similar age. Objective: To investigate the X inactivation pattern in patients with familial non-BRCA1/BRCA2 breast cancer (n = 272), BRCA1/BRCA2 germline mutations (n = 35), and sporadic breast cancer (n = 292). Methods: X inactivation pattern was determined by polymerase chain reaction analysis of the highly polymorphic CAG repeat in the androgen receptor (AR) gene. The X inactivation pattern was classified as skewed when 90% or more of the cells preferentially expressed one X chromosome. Results: Young patients with familial breast cancer had a significantly higher frequency of skewed X inactivation (11.2%) than young controls (2.7%) (p = 0.001). There was also a strong tendency for middle aged patients with sporadic breast cancer to be more skewed than middle aged controls (13.6% v 4.4%) (p = 0.02). No association between skewed X inactivation and breast cancer was found for the BRCA1/BRCA2 patients. Conclusions: Skewed X inactivation may be a risk factor for the development of breast cancer in both sporadic and familial breast cancer and may indicate an effect of X linked genes.
引用
收藏
页码:877 / 880
页数:4
相关论文
共 23 条
[21]   Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer [J].
Peto, J ;
Collins, N ;
Barfoot, R ;
Seal, S ;
Warren, W ;
Rahman, N ;
Easton, DF ;
Evans, C ;
Deacon, J ;
Stratton, MR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (11) :943-949
[22]   X inactivation in females with X-linked disease [J].
Puck, JM ;
Willard, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05) :325-328
[23]  
ZeladaHedman M, 1997, CANCER RES, V57, P2474